Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sarah Elizabeth Wakeman, M.D.

Co-Author

This page shows the publications co-authored by Sarah Wakeman and Susan Regan.
Connection Strength

4.885
  1. Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description. J Addict Med. 2021 Jun 17.
    View in: PubMed
    Score: 0.970
  2. A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation. Subst Abus. 2020 Dec 03; 1-8.
    View in: PubMed
    Score: 0.934
  3. Impact of Inpatient Addiction Consultation on Hospital Readmission. J Gen Intern Med. 2021 07; 36(7):2161-2163.
    View in: PubMed
    Score: 0.906
  4. The prevalence of unhealthy alcohol and drug use among inpatients in a general hospital. Subst Abus. 2020; 41(3):331-339.
    View in: PubMed
    Score: 0.852
  5. Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use. J Subst Abuse Treat. 2021 03; 122:108248.
    View in: PubMed
    Score: 0.234
  6. The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial. Subst Abus. 2020 Sep 03; 1-8.
    View in: PubMed
    Score: 0.230
  7. Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program. Int J Drug Policy. 2020 Apr 21; 79:102752.
    View in: PubMed
    Score: 0.224
  8. Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence. J Addict Med. 2019 Jul/Aug; 13(4):253-257.
    View in: PubMed
    Score: 0.212
  9. Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization. J Gen Intern Med. 2019 06; 34(6):871-877.
    View in: PubMed
    Score: 0.205
  10. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Sci Adv. 2021 Jun; 7(24).
    View in: PubMed
    Score: 0.061
  11. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug Alcohol Depend. 2021 01 01; 218:108438.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.